Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases

Cited by (743)

Items 701–743 of 743

1. Rapid regression of advanced hepatic fibrosis in a patient with metabolic dysfunction-associated steatotic liver disease and severe obesity: a case report highlighting lifestyle-induced NETosis activation through serum proteomic analysis
   Toru Nakamura, Shigemune Bekki, Dan Nakano, Atsutaka Masuda, Keisuke Amano, Masahito Nakano, Takumi Kawaguchi · 2026 · Clinical Journal of Gastroenterology
2. Fibrotic NASH Index ( FNI ) Is Associated with Long‐Term Mortality in Individuals with Type 2 Diabetes and MASLD
   Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Alessandro Oldani, Maria Neve Hirsch, Marta Cirelli, Marta Alfano, Maria Gisella Cavallo · 2026 · Liver International
3. Modified Freshwater Fish Oil Ameliorates Metabolic Disorders by Modulating Gut Microbiota and Liver Metabolism in High-Sucrose High-Fat Diet-Fed Mice
   Jinlin Li, Huijuan Zhou, Linchuan Xu, Junru Bai, Yanan Sun, Hao Wang, Chengwei Yu, Mingming Hu, Bizhen Zhong, Zongcai Tu et al. · 2026 · Journal of Agricultural and Food Chemistry
4. Hepatic lipid quantity and quality in type 2 diabetes mellitus
   Kahori Shimizu, Hideo Shindou, Koji Tomita, Hiroyuki Mizuguchi · 2026 · Frontiers in Pharmacology
5. L-Theanine ameliorates high-protein diet-associated hepatic glucose and lipid metabolic alterations by promoting fatty acid β-oxidation and suppressing lipid synthesis and gluconeogenesis in rats
   Sha Liu, Lanlan Li, Kai Yao, Lin He, Yong Yuan, Yueping Tan, Feiyan Yin, Zhihua Gong, Wenjun Xiao · 2026 · Current Research in Food Science
6. Camelina seeds and their glucosinolate, glucocamelinin, counteract severe fatty liver in rodents with monogenic obesity
   Adam Jurgoński, Paulina Opyd, Dorota Napiórkowska, Bartosz Fotschki, Łucja Brzuzan · 2026 · Genes & Nutrition
7. Machine Learning-Based Prediction of Comprehensive Lipid Response to Dietary Interventions in Overweight and Obese Women
   Shula Shazman · 2026 · Nutrients
8. Case Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation
   Yuri Tanaka, Hiroaki Ueno, Hirotake Sawada, Ayaka Konagata, Taisuke Uchida, Yudai Uehira, Fumiko Kogo, Akari Sekishima, Hiroshi Moritake, Hideki Yamaguchi et al. · 2026 · Frontiers in Endocrinology
9. Associations of insulin resistance-related indices with the risk and progression of cardiometabolic multimorbidity in individuals with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
   Mengtong Sun, Qida He, Yuxing Wang, Jiazhen Yao, Yueping Shen, Zhifen Liu, Qiang Han · 2026 · Cardiovascular Diabetology
10. Diagnostic performance of neck circumference for detecting steatotic liver disease in adults: a systematic review and meta-analysis protocol
    E. G. Abdurakhmanova, Aigerim Bolatbek, Nurmakhan Zholshybek, Zhadyra Mustafa, Joseph U. Almazan, Srinivasa Rao Bolla · 2026 · BMJ Open
11. Female-specific m6A remodeling in the liver correlates with post-transcriptional metabolic adaptation to high fat diet
    Sofia V. Krylova, Maxwell Horton, G Bucciarelli, Li Liu, Jacob L. Berrigan, Ronald Cutler, Kartik Chandran, Nathaniel W. Snyder, Toma Tebaldi, Simone Sidoli et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
12. Sini San ameliorates cholestatic liver injury by intrahepatically activating PPARα
    Fanghong Li, Xiaojiaoyang Li, Yajie Cai, Yufei Li, Yang Yang, Jianan Li, Ruiyu Wu, Ranyi Luo, Rong Sun, Runping Liu · 2026 · Chinese Herbal Medicines
13. Relationship between metabolic dysfunction-associated steatotic liver disease and cardiovascular mortality risk in individuals with CKM stages 0–2: Mediating roles of inflammation and insulin resistance
    Zhuoxing Li, Qianyu Yang, Li Zang, Hongwei Leng, Panpan Qin, Simeng Li, Buyuan Tian, Xumao Deng, Yun Sun, Xiang Xiao · 2026 · Diabetes Research and Clinical Practice
14. Nutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD)
    Muhammad Yasir Naeem, Tabinda Ijaz · 2026 · Food Science and Biotechnology
15. Inhibition of the CYP2E1-19-HETE-BLT2-mediated oxidative injury amplification by FGF21 alleviates myocardial infarction remodeling
    Guangsen Xu, Guiyun Wang, Yihan Fang, Lingjia Dong, Yongguo Xue, Qiyang Feng, Jiajia Jin, Yanqi Ruan, Huichan Chen, Bingyan Han et al. · 2026 · Free Radical Biology and Medicine
16. Physicochemical, nutritional and biological characterization of different Indian monofloral honeys with special emphasis on their glucose-lowering efficacy
    Chandrachur Ghosh, Somsuvra Chatterjee, Tiyasa Pathak, Tathagata Kundu, Surendra Saini, Debabrata Sircar, Prabhat Kumar, Partha Roy · 2026 · Food Chemistry X
17. Patolakaturohiniyadi Kashayam , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signalling
    Sania Kouser, Subrahmanya Kumar Kukkupuni, Poornima Devkumar, Chethala N. Vishnuprasad · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
18. The new TRR 412 Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathophysiological Mechanisms to Translation into Tailored Therapeutic Concepts (Berlin / Dresden)
    Frank Tacke, Katharina M Detjen, Juliane Heisig, Jochen Hampe · 2026 · Zeitschrift für Gastroenterologie
19. An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD
    Ao Dong, Na Li, Xiping Lang, Shunkai Chen, Yifeng Qin, Yuhang Wang, Haisheng Wang, Miaomiao Guo, Aomei Yan, Kai Song et al. · 2026 · Molecular Therapy — Nucleic Acids
20. Assessment of Severity of Metabolic Dysfunction–Associated Steatotic Liver Disease and Cardiovascular Risk in Individuals with and without Diabetes
    Manoj Mathur, Poonam Gupta, Pratham Agarwal, Ajeet Kumar Chaurasia, Divya Chutani · 2026 · SN Comprehensive Clinical Medicine
21. Homologous oridonin-loaded plant extracellular vesicles ameliorate metabolic-associated fatty liver disease by regulating lipid metabolism via the PPARγ/NLRP3-related pathway
    Xiaocong Dong, Xiangjuan Wei, Yichen He, Jiulong Du, Yixiao Bao, Jinglei Qiu, Zixuan Li, Wenbin Nan, Hongli Chen · 2026 · International Journal of Biological Macromolecules
22. Risk stratification of MASLD/MASH in type 2 diabetes: a pragmatic endocrinology outpatient pathway
    Yulan Cai, Feng Zeng, Chuyu Liu · 2026 · Frontiers in Endocrinology
23. Carnosic Acid improves the growth performance of Rice Field Eel (Monopterus albus) fed a high-carbohydrate diet: regulation of hepatic glycolipid metabolism, attenuation of liver injury, and restoration of intestinal health
    Yingming Xie, Jinchang Yang, Xu Yang, Meizhi Zhang, Kai Xie, Quan Li, Yi Hu, Shude Xu · 2026 · Animal Advances
24. A pan-tissue multi-omics resource atlas of coordinated immune, metabolic, and fibrotic alterations in diet-induced MASH
    Huajing Yu, Shanshan Liu, Yiqiao Zhang, Yu Ji, Yiyang Min, Danyang Yin, Tingting Wang, Xuemei Ma, Jionghuang Chen, Weihua Yu et al. · 2026 · iScience
25. Global landscape of clinical trials and therapeutic targets in metabolic dysfunction-associated steatotic liver disease: an integrative multi-omics analysis
    Yanxi Mu, Weixiong Zhu, Zhihao Wei, Zhao Guo, Haofei Chen, Yusheng Cheng, Wence Zhou · 2026 · Journal of Endocrinological Investigation
26. Modified Citrus Pectin-Mediated Gal-3 Reduction Attenuates Metabolic Dysfunction-Associated Steatohepatitis in an Experimental Model
    Anne R. M. Santos, Alessandra Gonçalves da Cruz, Felipe Nunes de Camargo, Jéssica Denielle Matos dos SANTOS, Jorge Felipe Argenta Model, José F. T. Silva, Sandro Leão Matos, Layanne C. C. Araujo, João Paulo Camporez · 2026 · Cells
27. Waist-to-height ratio reveals hidden metabolic risk in lean individuals with MASLD
    Z.-G. Wang, Wentao Tan, Jing Luo, Herui Wei, Wen An, Mengqi Li, Qi Gao, Lijuan Sun, Lingling He, Jiali Ma et al. · 2026 · Clinical Nutrition ESPEN
28. Combined transcriptomic and metabolomic profiling uncovers the mechanisms of silver nanoparticle-induced non-alcoholic fatty liver disease progression in ApoE −/− mice
    Yi Yang, Ziyan Zhou, Chunyang Liang, Xiaoxia Ou, Ying Ji, Yinqing Zhang · 2026 · Environmental Science Nano
29. Material-specific modulation of microplastic biotoxicity by chlorination: Mechanistic insights into ER stress and associated health risks
    Linxiang Lyu, Li Xiao, Zhikun Chen, Xiaohan Yang, Huifang Bi, He Peng, Shuyan Wan, Huaixiang Tian, Qian Tan, Chunjiang An · 2026 · Journal of Hazardous Materials
30. From famine to NAFLD: long-term association between fetal famine exposure and adult non-alcoholic fatty liver disease
    Xiaoli Zhang, Peiwen Dong, Minfang Lian, Lin Li · 2026 · Frontiers in Medicine
31. Early-pregnancy BMI-derived adiposity change rate and gestational diabetes mellitus risk: modification by a fatty liver index–defined hepatic-metabolic phenotype
    Jing Zhao, Yingjie Chen, Mengjia Peng, Binbin Shao, Jian Zhu, Hong Cao · 2026 · Frontiers in Endocrinology
32. Effects of Short‐Term Energy Limitation at Different Levels With Normal Protein Intake on Hepatic Lipid Metabolism and the Gut Microbiota in Overweight/Obese Mice
    Ying Tian, Yao Tang, Mingxia Gu, Jiawei Gong, Ying Zhou, Yuqing He, Keyu Huang · 2026 · Food Science & Nutrition
33. Restoration of fatty liver enzymes and oxidative stress markers with Stevia rebaudiana, Rebaudioside-A, and Aspartame: a comparative study in diet-induced obesity
    Sadia Mubarak, Anfal Khan, Amna Faruqi, Aruba Khan, Saira Safdar, Asma Irfan, Tooba Zafar, Saima Latif Qureshi · 2026 · Comparative Clinical Pathology
34. Endocrine determinants of MASLD: mechanisms and therapeutic targets
    Richa Chaturvedi, Anu Mathew, Aprajita Pradhan, Monika Goyal, Monika Sharma, Varsha Kachroo, Chhavi Agrawal, Aishwarya Krishnamurthy, Surabhi Madhwal Atreja, Ashish Atreja · 2026 · Frontiers in Endocrinology
35. Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis
    Da Lin, Gengbin Lin, Zhe Liu · 2026 · Frontiers in Medicine
36. Association of protein signature of fine particulate matter with MASLD: the underlying pathways and Mendelian randomization analysis
    Shanshan Ran, Dashan Zheng, Zijun Yang, Yin Yang, Shengtao Wei, Peng Hu, Jingyi Zhang, Fei Tian, Hualiang Lin · 2026 · Journal of Advanced Research
37. Research progress on ATP-citrate lyase and its inhibitors: a metabolic-epigenetic perspective
    Qinglin Liu, Hongbin Sun, Liang Dai · 2026 · Journal of Enzyme Inhibition and Medicinal Chemistry
38. Peptide profiling of casein peptide reveals its anti-diabetic effects via DPP-IV inhibition and IRS1/PI3K/AKT signaling
    Shengnan Liang, Jiarui Li, Zifu Zhao, Yiming He, Jingwen Wang, Lu Zhang, Chun Li, Libo Liu, Guofang Zhang, Jian He · 2026 · Food & Function
39. Next-Level Research on Metabolic Syndrome and Renal Function: A Review Targeted at Molecular and Genetic Endpoints
    Anajúlia Myrrha, Dianne Araújo Vieira, Anamel Blaudt-Meira, Cristiano Cardoso Carvalho, Lehallys Hache Vizzoni, Laura Almeida Rocha, Ingrid da Silva Rivelo, Pedro Henrique Costa Moreira, Beatriz Xavier Ferreira, Marcella Chagas-Sena et al. · 2026 · IntechOpen eBooks
40. Comparative Discriminative Performance of the HbA1c/HDL‐C Ratio, Stress Hyperglycemia Ratio, and ZJU Index for HOMA‐IR‐Defined Insulin Resistance in Patients With Type 2 Diabetes
    Zhangna Zheng, Qianyi Li, Huijuan Zhang · 2026 · International Journal of Endocrinology
41. Serum biomarkers and non-invasive indices for discriminating MASLD among adults with dysglycaemia
    Kübranur Ünal, Leyla Ibrahimkhanlı, Mehmet Emre Erol, Sabri Engin Altıntop, Nemat Ibrahimkhanli, Halit Nahit Şendur, Mahi Nur Cerit, Ethem Turgay Cerit · 2026 · Open Medicine
42. New perspectives in alleviating MASLD: synergism and prospects of exercise and natural products
    Qiuyue Wu, Jinxiu Li, Baoxuan Lin, Hailiang Xu, Ning Chen · 2026 · Food Science and Human Wellness
43. BindingDB Entry 50019754: Dihydrotrichodimerol Purified from the Marine Fungus
    BindingDB · 2024 · UC San Diego